Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Medtronic PLC | 75 |
| 2 | Corteva Inc | 31 |
| 3 | Massachusetts Institute of Technology | 22 |
| 4 | Pfizer Inc | 22 |
| 5 | University of Nebraska System | 17 |
| 6 | The University of Texas System | 15 |
| 7 | Mitsui & Co Ltd | 14 |
| 8 | Mass General Brigham Inc | 13 |
| 9 | Government of the United States of America | 12 |
| 10 | Boston Children's Hospital | 11 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 560 |
| 2 | A61P | Therapeutic activity (drug indications) | 433 |
| 3 | A23K | Animal feeds | 189 |
| 4 | C12N | Microorganisms, enzymes | 177 |
| 5 | Y02A | Climate change adaptation | 122 |
| 6 | C07K | Peptides | 112 |
| 7 | A61B | 50 | |
| 8 | C12R | 46 | |
| 9 | A61F | 44 | |
| 10 | A61L | Sterilising / disinfecting materials | 41 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee |
|---|---|---|
| Preparation method of suspension containing bacitracin methylenedisalicylic acid and robenidine | 2015 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 3 |
| 2024 | 4 |
| 2025 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | M.D. Sims | Graf Research (United States) | 5 |
| 2 | P.W. Waldroup | University of Arkansas at Fayetteville | 3 |
| 3 | Hyun S. Lillehoj | Beltsville Agricultural Research Center | 3 |
| 4 | RALPH V. FELL | 3 | |
| 5 | Greg F. Mathis | U.S. National Poultry Research Center | 3 |
| 6 | Yewande O. Fasina | North Carolina Agricultural and Technical State University | 2 |
| 7 | R.A. PRIMO | Rocky Mountain Research (United States) | 2 |
| 8 | Michael C. Brumm | Concordia University | 2 |
| 9 | Wilmer J. Pacheco | Auburn University | 2 |
| 10 | W.A. Dozier | Auburn University | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Effects of Dietary Mannan Oligosaccharide, Bacitracin Methylene Disalicylate, or Both on the Live Performance and Intestinal Microbiology of Turkeys | 2004 | 204 | Animal Nutrition and Physiology |
| Effects of a Buffered Propionic Acid in Diets on the Performance of Broiler Chickens and on Microflora of the Intestine and Carcass | 1990 | 144 | Animal Nutrition and Physiology |
| The Effects of Direct-fed Microbial Supplementation, as an Alternative to Antibiotics, on Growth Performance, Intestinal Immune Status, and Epithelial Barrier Gene Expression in Broiler Chickens | 2017 | 116 | Animal Nutrition and Physiology |
| Beneficial Effect of β-Mannanase Feed Enzyme on Performance of Chicks Challenged with Eimeria sp. and Clostridium perfringens | 2003 | 96 | Animal Nutrition and Physiology |
| Effects of Feed Additives and Mixed Eimeria Species Infection on Intestinal Microbial Ecology of Broilers | 2006 | 93 | Animal Nutrition and Physiology |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Bacitracin methylenedisalicylic acid?
Which organizations hold the most patents related to this compound?
What are the primary research topics in published papers on this compound?
How has patent activity for this compound changed in recent years?
What patent classification areas dominate the intellectual property landscape for this compound?